Schedule 13G ownership disclosure
Nurix Therapeutics Inc
Security class unavailable · CUSIP: 67080M103
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,482,105
- Percent of class
- 5.4100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-24-000475
- Form type
- SC 13G
- Filer
- Nurix Therapeutics, Inc.
- CIK
- CIK 1549595
- Filed
- Nov 08, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership